Navigation Links
ADHD Treatments To Be Compared In Public Webinar
Date:11/2/2009

Hayes to offer public webinar to help parents of children with ADHD understand the scientific evidence behind a range of ADHD treatments

Lansdale, PA (PRWEB) November 2, 2009 -- www.hayesinc.com [Hayes, Inc., the nation’s leading health technology research and consulting company, today announced that it is offering a consumer-oriented webinar that will unlock the scientific evidence behind various treatments for attention-deficit/hyperactivity disorder (ADHD). In the webinar, Hayes analysts will provide a clear perspective on the benefits, limitations, and potential side effects of a range of ADHD treatments, including pharmaceutical and behavioral approaches.

Hayes CARE professionals will present the webinar. The Hayes CARE program is an innovative workplace benefit for employees and their families. The information provided by Hayes CARE helps employees to understand treatment options, maintain or regain control over their own healthcare decisions, and cope with disruptive health events.    

ADHD impacts 4 to 5 million American children, and its treatment is controversial. During the webinar, Elisabeth Houtsmuller (Ph.D.) will explore the clinical evidence behind ADHD treatments for children and cover the benefits and limitations of each, taking into consideration the severity of the symptoms.

In commenting on the webinar, Dr. Houtsmuller said, “Parents of children with ADHD are often overwhelmed by differing opinions about the effectiveness of the various treatments. It is difficult to find unbiased information about treatments, and the Internet is cluttered with conflicting data, some of which has been provided by drug companies with products to sell. At the same time, ADHD is a “lightning rod” issue, and opinions abound from relatives, friends, and neighbors, adding to the confusion.”

“In our webinar, we will provide an unbiased view of ADHD treatments, including prescription drugs such as Adderall® and Strattera®, behavioral therapies, neurofeedback, and over-the-counter treatments such as St. John’s wort and Ginkgo biloba. Our hope is that parents will have the opportunity to learn about treatment options in a forum that is free from the influence of any drug manufacturers, special interest groups, or other marketing biases.”

The one-hour interactive webinar will be offered on November 12, 2009 at 12:00 PM Eastern time and again at 9:00 PM Eastern time. Participants will be able to ask questions through the web-based software. Participants will also receive easy-to-use take-home guides that summarize the information discussed during the program. The registration fee of $19.95 includes all materials.

Dr. Houtsmuller continued, “It is important for parents to be involved in decisions about how to treat their children with ADHD. There are so many options, and most parents don’t have access to the scientific literature. At the same time, finding and calibrating the right treatment for children with ADHD can create family stress. We hope that by offering this webinar we can provide parents with an unbiased and broad perspective to make these challenging and stressful decisions.”

About Hayes, Inc.:
Hayes, Inc. is an independent health technology research and consulting company dedicated to promoting better health outcomes through the use of evidence. Hayes performs unbiased, evidence-based health technology assessments of the safety and efficacy of new, emerging, and controversial health technologies, and evaluates the impact of these technologies on healthcare quality, utilization, and cost. Hayes' worldwide clients include hospitals, healthcare systems, government agencies, employers, and managed care organizations. http://www.hayesinc.com.

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3147594.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Money Woes Keeping Many Couples From Fertility Treatments
2. Radiation Treatments Made Safer for Cancer Patients
3. Fine-tuning treatments for depression
4. Studying cancer in pet dogs to find new treatments for human patients
5. DNA test could be key to targeting treatments for head and neck cancer
6. Chronic pain treatments work better together, says anesthesiologist
7. $16.8 million grant awarded to develop platelet recovery treatments
8. Dr. Marc Katz, Leading Podiatric Surgeon Adds High Powered Color Ultrasound To Cryosurgery Procedures and Treatments
9. New Treatments Hold Hope for Failing Eyes
10. National Autism Center Releases Groundbreaking Report on Autism Treatments
11. Women's Pelvic Organ Prolapse and Incontinence Guide Informs, Outlines Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device ... precise destruction of targeted tissues, announced three leadership team developments today:   ... Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: